US EditionPublished • loading... • Updated
Cancer Diagnosis and Treatment: Radiopharmacy Cluster Dresden
Summary by mdr.de
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Radiopharma industry is placing quarter billions in new cyclotrons and other plants – some of them mourning after Rossendorfer Meiler Dresden/Radeberg, January 8, 2026. Because the world market for radiopharmaceutical cancer drugs is growing by 34 percent per year, the companies and institutes of the association "Nuclide" want to invest in the next few years in Dresden and Radeberg an almost quarter billion euros in more powerful cyclotrons, cle…
Saxony is a leader in radiopharmacy: the nuclear medicine method diagnoses and treats tumors specifically in the diseased tissue. The Radiopharmacy Cluster Dresden was founded in Dresden.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
